Published in Obesity (Silver Spring) on January 14, 2010
H2S-Induced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response. Sci Signal (2011) 2.70
Targeting the disordered C terminus of PTP1B with an allosteric inhibitor. Nat Chem Biol (2014) 1.40
Targeting protein tyrosine phosphatases for anticancer drug discovery. Curr Pharm Des (2010) 1.10
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. J Med Chem (2011) 1.00
Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance. J Pharmacol Exp Ther (2014) 0.88
Current and future drug targets in weight management. Pharm Res (2010) 0.88
Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK/PTK6 in ovarian cancer cells. J Biol Chem (2013) 0.88
New pharmacological perspectives for the leptin receptor in the treatment of obesity. Front Endocrinol (Lausanne) (2014) 0.86
Significance of endangered and threatened plant natural products in the control of human disease. Proc Natl Acad Sci U S A (2013) 0.84
Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs. Bioorg Med Chem Lett (2010) 0.83
Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases. Future Sci OA (2015) 0.81
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes. Nat Rev Drug Discov (2016) 0.80
Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase. J Biol Chem (2015) 0.79
MSI-1436 reduces acute food intake without affecting dopamine transporter activity. Pharmacol Biochem Behav (2010) 0.78
Receptor-Interacting Protein 140 Orchestrates the Dynamics of Macrophage M1/M2 Polarization. J Innate Immun (2015) 0.78
The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol (2017) 0.77
Obesity pharmacotherapy: current perspectives and future directions. Curr Cardiol Rev (2013) 0.77
Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer's Therapy? Front Aging Neurosci (2017) 0.77
Effects of hepatic protein tyrosine phosphatase 1B and methionine restriction on hepatic and whole-body glucose and lipid metabolism in mice. Metabolism (2014) 0.76
Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer. Clin Cancer Res (2017) 0.75
Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens. Nat Neurosci (2007) 4.97
Regional specificity in the real-time development of phasic dopamine transmission patterns during acquisition of a cue-cocaine association in rats. Eur J Neurosci (2009) 2.22
Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration. Neuropsychopharmacology (2005) 2.14
Nucleus accumbens neurons encode Pavlovian approach behaviors: evidence from an autoshaping paradigm. Eur J Neurosci (2006) 1.41
Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens. J Neurochem (2012) 1.37
Primary food reward and reward-predictive stimuli evoke different patterns of phasic dopamine signaling throughout the striatum. Eur J Neurosci (2011) 1.36
Identification of CKAP4/p63 as a major substrate of the palmitoyl acyltransferase DHHC2, a putative tumor suppressor, using a novel proteomics method. Mol Cell Proteomics (2008) 1.28
Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens. Psychopharmacology (Berl) (2010) 1.24
Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron (2012) 1.13
Encoding of aversion by dopamine and the nucleus accumbens. Front Neurosci (2012) 1.13
Ghrelin acts as an interface between physiological state and phasic dopamine signaling. J Neurosci (2014) 1.07
Risk-preference differentiates orbitofrontal cortex responses to freely chosen reward outcomes. Eur J Neurosci (2010) 1.07
New insights into the specificity and plasticity of reward and aversion encoding in the mesolimbic system. J Neurosci (2013) 1.07
Taste uncoupled from nutrition fails to sustain the reinforcing properties of food. Eur J Neurosci (2012) 1.02
Sucrose-predictive cues evoke greater phasic dopamine release than saccharin-predictive cues. Synapse (2011) 1.01
Electrode calibration with a microfluidic flow cell for fast-scan cyclic voltammetry. Lab Chip (2012) 0.94
Interleukin-9 induces mucous cell metaplasia independent of inflammation. Am J Respir Cell Mol Biol (2003) 0.94
Nucleus accumbens shell, but not core, tracks motivational value of salt. J Neurophysiol (2011) 0.91
Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression. PLoS One (2013) 0.91
Statistical algorithm for assuring similar efficiency in standards and samples for absolute quantification by real-time reverse transcription polymerase chain reaction. Anal Biochem (2005) 0.90
Squalamine lactate reduces choroidal neovascularization in a laser-injury model in the rat. Retina (2003) 0.86
Forebrain dopamine neurons project down to a brainstem region controlling locomotion. Proc Natl Acad Sci U S A (2013) 0.86
Nicotinic receptors regulate the dynamic range of dopamine release in vivo. J Neurophysiol (2013) 0.81
STa peptide analogs for probing guanylyl cyclase C. Biopolymers (2008) 0.78
MSI-1436 reduces acute food intake without affecting dopamine transporter activity. Pharmacol Biochem Behav (2010) 0.78
Post-translational modification of transcription factors: mechanisms and potential therapeutic interventions. Curr Mol Pharmacol (2013) 0.75